| First Author | Brusilovsky M | Year | 2021 |
| Journal | Nat Immunol | Volume | 22 |
| Issue | 10 | Pages | 1316-1326 |
| PubMed ID | 34531562 | Mgi Jnum | J:320753 |
| Mgi Id | MGI:6874458 | Doi | 10.1038/s41590-021-01011-2 |
| Citation | Brusilovsky M, et al. (2021) Environmental allergens trigger type 2 inflammation through ripoptosome activation. Nat Immunol 22(10):1316-1326 |
| abstractText | Environmental allergens, including fungi, insects and mites, trigger type 2 immunity; however, the innate sensing mechanisms and initial signaling events remain unclear. Herein, we demonstrate that allergens trigger RIPK1-caspase 8 ripoptosome activation in epithelial cells. The active caspase 8 subsequently engages caspases 3 and 7, which directly mediate intracellular maturation and release of IL-33, a pro-atopy, innate immunity, alarmin cytokine. Mature IL-33 maintained functional interaction with the cognate ST2 receptor and elicited potent pro-atopy inflammatory activity in vitro and in vivo. Inhibiting caspase 8 pharmacologically and deleting murine Il33 and Casp8 each attenuated allergic inflammation in vivo. Clinical data substantiated ripoptosome activation and IL-33 maturation as likely contributors to human allergic inflammation. Our findings reveal an epithelial barrier, allergen-sensing mechanism that converges on the ripoptosome as an intracellular molecular signaling platform, triggering type 2 innate immune responses. These findings have significant implications for understanding and treating human allergic diseases. |
